about
Nerve growth factor inhibits metalloproteinase-disintegrins and blocks ectodomain shedding of platelet glycoprotein VIA mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet functionExtracorporeal membrane oxygenation-hemostatic complications.Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura.Measuring soluble platelet glycoprotein VI in human plasma by ELISA.Proteolysis of platelet receptors in humans and other species.Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets.Focusing on plasma glycoprotein VI.Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI.DiagnoSTic assays for heparin-induced thrombocytopenia.An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets.The platelet Fc receptor, FcγRIIa.Metalloproteolytic receptor shedding…platelets "acting their age".Targeting GPVI as a novel antithrombotic strategy.An absence of platelet activation following thalidomide treatment in vitro or in vivo.Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors.CLEC-2 expression is maintained on activated platelets and on platelet microparticles.Platelet adhesion receptors and (patho)physiological thrombus formation.Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.Glycoprotein Ib-IX-V.Platelet interactions in thrombosis.Structure-activity relationships of snake toxins targeting platelet receptors, glycoprotein Ib-IX-V and glycoprotein VI.Methods to Determine the Lagrangian Shear Experienced by Platelets during Thrombus Growth.Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase.Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood.Role of calmodulin in platelet receptor function.Platelet receptor proteolysis: a mechanism for downregulating platelet reactivity.Programmed autologous cleavage of platelet receptors.Exacerbation of glycoprotein VI-dependent platelet responses in a rhesus monkey model of Type 1 diabetesPlatelet receptor redox regulation.Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol.14-3-3ζ regulates the mitochondrial respiratory reserve linked to platelet phosphatidylserine exposure and procoagulant function.Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets.Platelet receptor shedding.Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction.Structure and function of platelet receptors initiating blood clotting.Rabbit polymorphonuclear neutrophils form 35S-labeled S-sulfo-calgranulin C when incubated with inorganic [35S]sulfate.
P50
Q24299819-CF174CE3-17DC-48D7-BCC3-B8EC939A4A0BQ24309485-01B95C89-DAB8-4CA2-A10A-89EBEC61D8F2Q28592055-C3AE0494-9D5E-4096-97FD-7B944DFC6CDDQ30370865-7EFBAC30-951A-4A39-AE90-5D91CB6CD26FQ33376631-93D2C41A-4B0D-414A-B2F1-1CCF7DBC2288Q33379632-918B65D2-5D84-4F7A-9424-7ACFFFB928F9Q33384477-69293B29-3A4F-49E0-9368-6F6E753EAB40Q33389665-F4EFD9F4-2B50-4AA8-BFF4-42D563D563CCQ33395784-022C36B7-291D-4BE0-BA79-07E8FC7A5957Q33399327-1EDB91E8-835A-4960-AD7F-AB4C5C8F73F4Q33414254-DC43D325-7E56-4FBF-8DCA-888FFBFEF558Q33415273-8C6E6615-6AAF-499C-A775-14072A88659EQ33422982-2EA0A977-1E0D-449A-B884-F1597893914FQ33427010-64BF6D8E-306F-471E-B04A-16599AED376AQ33434155-39529D9D-A054-452E-9514-1F0CE570FDBFQ33689745-54D304FE-5BBC-46A6-A28E-A59AAA16CF10Q33829306-F98F0948-DD48-444A-8D80-542AC6144CC2Q33842408-E9E1E45A-1074-462A-A59F-A73A06704665Q33892532-025FB044-D65C-4B17-86C8-8DB66A9E880AQ34284335-34F2BD1D-6A92-461E-9DE7-38E769B11D3EQ34340376-987E9174-13A3-49E7-B76F-23D5AF8239D0Q35064907-C4DAF012-0519-4EEB-869D-844194232309Q35131686-10C062FD-1C8F-4766-B944-AB9072E13E01Q35678929-58AB001D-ACE1-49F9-8FCA-A1A9B12035FFQ35867062-7BBCE057-E645-4357-A27C-55E4BCD57A8AQ35867529-D6D84B63-D89C-4DBE-94FC-2D1E75FA7476Q35966249-F4A04A16-13C5-4068-819B-08B51A9E668DQ36215984-724AAABC-B299-4561-8FE6-84D19B69B0B6Q36297698-7AB6440A-9A1E-47FF-A3FF-8261CD33E15FQ36803375-652DD877-791B-4636-B0A6-D916E944338BQ36884408-37E17A34-8350-4FF3-AAD1-4C5E28E3FE4FQ36948558-D0CC4D2C-3B2B-4EA1-867A-38062BB4A7C5Q37071700-B634175C-3946-4317-B591-BCA550557E43Q37190390-EEC63DDE-D840-4E47-97E9-3E02F5AC8A1DQ37314976-1282C1B6-F14F-418C-BA78-6CF48C6B1B10Q37696519-9C7924DF-4B96-41F8-9906-264F645182DAQ37963244-B90E3B3C-7B7F-4394-B623-030A469A0187Q38047533-551A2F9A-BEE2-48B7-9FE8-B7760D43524BQ38284012-68C0BB54-61C1-4A4E-86A1-9930154E61CCQ38354005-F958D16E-9B80-413F-8A04-122D0F99FE47
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elizabeth Gardiner
@ast
Elizabeth Gardiner
@en
Elizabeth Gardiner
@es
Elizabeth Gardiner
@sl
type
label
Elizabeth Gardiner
@ast
Elizabeth Gardiner
@en
Elizabeth Gardiner
@es
Elizabeth Gardiner
@sl
prefLabel
Elizabeth Gardiner
@ast
Elizabeth Gardiner
@en
Elizabeth Gardiner
@es
Elizabeth Gardiner
@sl
P106
P21
P2798
P31
P496
0000-0001-9453-9688